Minimal Residual Disease Market Expected to Reach USD 9.16 Billion by 2034, Driven by Advanced Diagnostics and Personalized Oncology Solutions
The global Minimal Residual Disease Market was valued at USD 2.53 billion in 2024 and is projected to reach USD 9.16 billion by 2034, exhibiting a CAGR of 13.7% during the forecast period. The market is being fueled by rising prevalence of hematologic malignancies, technological advancements in molecular diagnostics, and increasing adoption...
0 Comments 0 Shares 25 Views 0 Reviews